Analysts at StockNews.com assumed coverage on shares of Global Indemnity Group (NASDAQ:GBLI – Get Free Report) in a note issued to investors on Tuesday. The brokerage set a “buy” rating on the insurance provider’s stock.
Global Indemnity Group Stock Down 1.5 %
Shares of NASDAQ GBLI opened at $30.63 on Tuesday. The firm’s 50-day moving average price is $31.39 and its 200-day moving average price is $30.66. Global Indemnity Group has a 52-week low of $26.50 and a 52-week high of $37.00. The company has a market cap of $416.69 million, a PE ratio of 12.35 and a beta of 0.45.
Global Indemnity Group (NASDAQ:GBLI – Get Free Report) last issued its earnings results on Wednesday, May 8th. The insurance provider reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.60 by $0.17. The company had revenue of $112.29 million for the quarter, compared to analysts’ expectations of $90.00 million. Global Indemnity Group had a net margin of 6.98% and a return on equity of 5.40%. As a group, equities research analysts anticipate that Global Indemnity Group will post 2.55 EPS for the current fiscal year.
Institutional Investors Weigh In On Global Indemnity Group
Global Indemnity Group Company Profile
Global Indemnity Group, LLC, through its subsidiaries, provides specialty property and casualty insurance, and reinsurance products worldwide. It operates in two segments, Penn-America and Non-Core Operations. The company distributes property and general liability products for small commercial businesses through a network of wholesale general agents; and property and general liability niche products through program administrators with specific binding authority.
Further Reading
- Five stocks we like better than Global Indemnity Group
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Consumer Staples Stocks, Explained
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Global Indemnity Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Indemnity Group and related companies with MarketBeat.com's FREE daily email newsletter.